Literature DB >> 12455027

Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?

Philippe Anker1, Hugh Mulcahy, Maurice Stroun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12455027     DOI： 10.1002/ijc.10791

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  29 in total

1.  Comparative study of seven commercial kits for human DNA extraction from urine samples suitable for DNA biomarker-based public health studies.

Authors:  Latifa El Bali; Aurélie Diman; Alfred Bernard; Nancy H C Roosens; Sigrid C J De Keersmaecker
Journal:  J Biomol Tech       Date:  2014-12

2.  MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis.

Authors:  Chunming Ding; Rossa W K Chiu; Tze K Lau; Tse N Leung; Li C Chan; Amy Y Y Chan; Pimlak Charoenkwan; Ivy S L Ng; Hai-Yang Law; Edmond S K Ma; Xiangmin Xu; Chanane Wanapirak; Torpong Sanguansermsri; Can Liao; Mary Anne Tan Jin Ai; David H K Chui; Charles R Cantor; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

Review 3.  Advances in the medical research and clinical applications on the plasma DNA.

Authors:  Shuye Wang; Yuanyuan Chen; Zhanhe Wu
Journal:  Transl Pediatr       Date:  2014-04

4.  Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients.

Authors:  Thomas E Liggett; Anatoliy A Melnikov; Jeffrey R Marks; Victor V Levenson
Journal:  Int J Cancer       Date:  2010-04-05       Impact factor: 7.396

5.  On-chip wavelength multiplexed detection of cancer DNA biomarkers in blood.

Authors:  H Cai; M A Stott; D Ozcelik; J W Parks; A R Hawkins; H Schmidt
Journal:  Biomicrofluidics       Date:  2016-12-15       Impact factor: 2.800

6.  Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients.

Authors:  Ning Ren; Qing-Hai Ye; Lun-Xiu Qin; Bo-Heng Zhang; Yin-Kun Liu; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

7.  The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma.

Authors:  Ning Ren; Lun-Xiu Qin; Hong Tu; Yin-Kun Liu; Bo-Heng Zhang; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2006-02-25       Impact factor: 4.553

8.  Diagnostic and prognostic value of metastasis inducer S100A4 transcripts in plasma of colon, rectal, and gastric cancer patients.

Authors:  Ulrike Stein; Susen Burock; Pia Herrmann; Ina Wendler; Markus Niederstrasser; Klaus-Dieter Wernecke; Peter M Schlag
Journal:  J Mol Diagn       Date:  2011-03       Impact factor: 5.568

9.  An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma.

Authors:  Quynh-Thu Le; Qiang Zhang; Hongbin Cao; Ann-Joy Cheng; Benjamin A Pinsky; Ruey-Long Hong; Joseph T Chang; Chun-Wei Wang; Kuo-Chien Tsao; Ym Dennis Lo; Nancy Lee; K Kian Ang; Anthony T C Chan; K C Allen Chan
Journal:  Clin Cancer Res       Date:  2013-03-04       Impact factor: 12.531

10.  Salivary protein factors are elevated in breast cancer patients.

Authors:  Mai N Brooks; Jianghua Wang; Yang Li; Rong Zhang; David Elashoff; David T Wong
Journal:  Mol Med Rep       Date:  2008 May-Jun       Impact factor: 2.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.